Active Ingredient: BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Proprietary Name: BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3MG/ML;EQ 3MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A077838
Product Number: 001
Approval Date: Jan 17, 2023
Applicant Holder Full Name: HIKMA FARMACEUTICA PORTUGAL SA
Marketing Status:
Prescription
Patent and Exclusivity Information
